Connected profileLiraglutide
Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Liraglutide clinical trials
9 selected ClinicalTrials.gov records carrying the official matched intervention Liraglutide (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
Registry records
9 selected records.
Connected peptides
1 profiles.
Source boundary
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 54 selected PubMed records and 13 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
Record added
ClinicalTrials.gov record NCT03883412
PeptideScanner retained ClinicalTrials.gov record NCT03883412 at 2026-08-13T05:54:14.859Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was liraglutide.
- PeptideScanner change date
- August 14, 2026
- Cited source date
- August 12, 2026
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT05313529
PeptideScanner retained ClinicalTrials.gov record NCT05313529 at 2026-08-13T05:52:27.020Z. Its registry update date was 2026-08-06, and PeptideScanner's reviewed identity mapping was liraglutide.
- PeptideScanner change date
- August 14, 2026
- Cited source date
- August 6, 2026
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT01270789
PeptideScanner retained ClinicalTrials.gov record NCT01270789 at 2026-07-30T21:54:46.538Z. Its registry update date was 2014-09-12, and PeptideScanner's reviewed identity mapping was liraglutide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- September 12, 2014
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Liraglutide · 2026-08-12
ClinicalTrials.gov record NCT03883412
Recruiting at the retained observation.
Open attributed record →Liraglutide · 2026-08-06
ClinicalTrials.gov record NCT05313529
Completed at the retained observation.
Open attributed record →Liraglutide · 2026-07-09
ClinicalTrials.gov record NCT04775082
Active, not recruiting at the retained observation.
Open attributed record →Liraglutide · 2023-07-18
ClinicalTrials.gov record NCT03374956
Completed at the retained observation.
Open attributed record →Liraglutide · 2015-03-25
ClinicalTrials.gov record NCT01755572
Completed at the retained observation.
Open attributed record →Liraglutide · 2014-09-12
ClinicalTrials.gov record NCT01270789
Completed at the retained observation.
Open attributed record →Liraglutide · 2013-10-09
ClinicalTrials.gov record NCT01394341
Completed at the retained observation.
Open attributed record →Liraglutide · 2013-04-19
ClinicalTrials.gov record NCT01469351
Completed at the retained observation.
Open attributed record →Liraglutide · 2012-09-27
ClinicalTrials.gov record NCT01695109
Completed at the retained observation.
Open attributed record →